Uploads Contact
/
Login Upload

  • Search Results for 'Biosimilars Patients'

Biosimilars: Questions and Answers Regarding Implementation of the Bi
Biosimilars: Questions and Answers Regarding Implementation of the Bi
danika-pritchard
Biosimilars: Questions and Answers Regarding Implementation of the Bi
Biosimilars: Questions and Answers Regarding Implementation of the Bi
sherrill-nordquist
Biosimilars: Additional Questions and Answers Regarding Implementatio
Biosimilars: Additional Questions and Answers Regarding Implementatio
mitsue-stanley
Biosimilars: Additional Questions and Answers Regarding Implementatio
Biosimilars: Additional Questions and Answers Regarding Implementatio
liane-varnes
Interchangeable Biosimilars: The Future of Affordable MedicineFDA is i
Interchangeable Biosimilars: The Future of Affordable MedicineFDA is i
celsa-spraggs
Roche Position
Roche Position
faustina-dinatale
Phil Johnson MS
Phil Johnson MS
stefany-barnette
Biosimilars 2012 AIPLA Webinar
Biosimilars 2012 AIPLA Webinar
stefany-barnette
Faculty Leonard H. Calabrese, DO
Faculty Leonard H. Calabrese, DO
trish-goza
Recruitment of cancer patients by LCRN
Recruitment of cancer patients by LCRN
karlyn-bohler
Phil Johnson MS RPh Safe School Meds, Principle Partner
Phil Johnson MS RPh Safe School Meds, Principle Partner
yoshiko-marsland
Biosimilars: Regulation and Litigation
Biosimilars: Regulation and Litigation
mitsue-stanley
Stage 4 CKD presentation in patients over 75 Years Old differs from that in patients less
Stage 4 CKD presentation in patients over 75 Years Old differs from that in patients less
debby-jeon
Daclatasvir Plus Sofosbuvir With or Without Ribavirin in Patients With HCV Genotype 3
Daclatasvir Plus Sofosbuvir With or Without Ribavirin in Patients With HCV Genotype 3
kittie-lecroy
Biosimilars Guideline – a Summary of the Industry Comments
Biosimilars Guideline – a Summary of the Industry Comments
marina-yarberry
Comparison of US/EU Biosimilar
Comparison of US/EU Biosimilar
myesha-ticknor
Comparison of US/EU Biosimilar
Comparison of US/EU Biosimilar
aaron
Comparison of US/EU Biosimilar
Comparison of US/EU Biosimilar
danika-pritchard
Can we safely discharge TIA patients?
Can we safely discharge TIA patients?
min-jolicoeur
Which Myelofibrosis Patients are Candidates for Upfront Ste
Which Myelofibrosis Patients are Candidates for Upfront Ste
yoshiko-marsland
Update on transplant-ineligible patients:
Update on transplant-ineligible patients:
trish-goza
Partnership for Patients
Partnership for Patients
pamella-moone
Maintaining patients on anticoagulants: how to do it
Maintaining patients on anticoagulants: how to do it
olivia-moreira
Treatment of Hepatitis C in patients with
Treatment of Hepatitis C in patients with
tatyana-admore